Intravenous Solutions Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL INTRAVENOUS SOLUTIONS INDUSTRY

2.1 Summary about Intravenous Solutions Industry

2.2 Intravenous Solutions Market Trends

2.2.1 Intravenous Solutions Production & Consumption Trends

2.2.2 Intravenous Solutions Demand Structure Trends

2.3 Intravenous Solutions Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Crystalloids

4.2.2 Colloids

4.2.3 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Basic IV Solutions

4.3.2 Nutrient Infusion Solution

4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Crystalloids

5.2.2 Colloids

5.2.3 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Basic IV Solutions

5.3.2 Nutrient Infusion Solution

5.3.3 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Crystalloids

6.2.2 Colloids

6.2.3 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Basic IV Solutions

6.3.2 Nutrient Infusion Solution

6.3.3 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Crystalloids

7.2.2 Colloids

7.2.3 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Basic IV Solutions

7.3.2 Nutrient Infusion Solution

7.3.3 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Crystalloids

8.2.2 Colloids

8.2.3 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Basic IV Solutions

8.3.2 Nutrient Infusion Solution

8.3.3 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Crystalloids

9.2.2 Colloids

9.2.3 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Basic IV Solutions

9.3.2 Nutrient Infusion Solution

9.3.3 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Baxter

10.1.2 Hospira

10.1.3 B. Braun Melsungen

10.1.4 Fresenius Kabi

10.1.5 Claris Lifesciences

10.1.6 Grifols

10.1.7 Vifor Pharma

10.1.8 JW Life Science

10.2 Intravenous Solutions Sales Date of Major Players (2017-2020e)

10.2.1 Baxter

10.2.2 Hospira

10.2.3 B. Braun Melsungen

10.2.4 Fresenius Kabi

10.2.5 Claris Lifesciences

10.2.6 Grifols

10.2.7 Vifor Pharma

10.2.8 JW Life Science

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

1.Table Intravenous Solutions Product Type Overview

2.Table Intravenous Solutions Product Type Market Share List

3.Table Intravenous Solutions Product Type of Major Players

4.Table Brief Introduction of Baxter

5.Table Brief Introduction of Hospira

6.Table Brief Introduction of B. Braun Melsungen

7.Table Brief Introduction of Fresenius Kabi

8.Table Brief Introduction of Claris Lifesciences

9.Table Brief Introduction of Grifols

10.Table Brief Introduction of Vifor Pharma

11.Table Brief Introduction of JW Life Science

12.Table Products & Services of Baxter

13.Table Products & Services of Hospira

14.Table Products & Services of B. Braun Melsungen

15.Table Products & Services of Fresenius Kabi

16.Table Products & Services of Claris Lifesciences

17.Table Products & Services of Grifols

18.Table Products & Services of Vifor Pharma

19.Table Products & Services of JW Life Science

20.Table Market Distribution of Major Players

21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

23.Table Global Intravenous Solutions Market Forecast (Million USD) by Region 2021f-2026f

24.Table Global Intravenous Solutions Market Forecast (Million USD) Share by Region 2021f-2026f

25.Table Global Intravenous Solutions Market Forecast (Million USD) by Demand 2021f-2026f

26.Table Global Intravenous Solutions Market Forecast (Million USD) Share by Demand 2021f-2026f